TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PINK Stock 12 Month Forecast
There Are No Analyst Ratings for TSE:PINK In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
PINK Financial Forecast
PINK Earnings Forecast
Next quarter’s earnings estimate for PINK is -C$0.03 with a range of -C$0.03 to -C$0.03. The previous quarter’s EPS was -C$0.04. PINK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year PINK has Performed in-line its overall industry.
Next quarter’s earnings estimate for PINK is -C$0.03 with a range of -C$0.03 to -C$0.03. The previous quarter’s EPS was -C$0.04. PINK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year PINK has Performed in-line its overall industry.
PINK Sales Forecast
Next quarter’s sales forecast for PINK is C$1.24M with a range of C$1.24M to C$1.24M. The previous quarter’s sales results were C$738.38K. PINK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year PINK has Performed in-line its overall industry.
Next quarter’s sales forecast for PINK is C$1.24M with a range of C$1.24M to C$1.24M. The previous quarter’s sales results were C$738.38K. PINK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year PINK has Performed in-line its overall industry.
Perimeter Medical Imaging is a buy, Leede saysThe results, presented at the American Society of Breast Surgeons annual meeting, strengthen Loes view that regulatory clearance is likely. He said B-Series could meaningfully improve breast cancer surgery outcomes by enabling real-time identification of residual tumour margins, something not possible with standard biopsy or visual inspection.
Perimeter Medical Imaging is a buy, Leede saysThe results, presented at the American Society of Breast Surgeons annual meeting, strengthen Loes view that regulatory clearance is likely. He said B-Series could meaningfully improve breast cancer surgery outcomes by enabling real-time identification of residual tumour margins, something not possible with standard biopsy or visual inspection.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -32.40% per trade.
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -32.30% per trade.
Copying Douglas Loe's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -31.80% per trade.
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -46.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PINK Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, PINK has received 0Buy Ratings, 0Hold Ratings, and 0Sell Ratings. PINK average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
PINK Stock Forecast FAQ
What is TSE:PINK’s average 12-month price target, according to analysts?
Currently, no data Available
What is TSE:PINK’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TSE:PINK, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSE:PINK a Buy, Sell or Hold?
Currently, no data Available
What is Perimeter Medical Imaging AI’s price target?
Currently, no data Available
What do analysts say about Perimeter Medical Imaging AI?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of TSE:PINK?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.